ETON today
$63.93+$2.48 (+4.04%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns down below $47.03
Key levels
Resistance$66.37
Support$59.66
Support$53.98
Latest news & SEC filings
SEC FilingEton Pharmaceuticals, Inc. filed an insider trading report (Form 4)
NewsEton Pharmaceuticals Insider Sells $5.3 Million in Shares
AnalystB. Riley Securities keeps Buy rating on Eton Pharmaceuticals, lifts target to $81
All ETON news →About Eton Pharmaceuticals
Eton Pharmaceuticals is a pharmaceutical company that develops and commercializes treatments for rare diseases. It markets products for endocrine and metabolic conditions, including INCRELEX, ALKINDI SPRINKLE, KHINDIVI, GALZIN, PKU GOLIKE, and generic versions of Carglumic Acid, Betaine Anhydrous, and Nitisinone. The company sells to healthcare providers and patients in the United States through specialty pharmacies and its own sales force. It also has several experimental medicines in advanced testing.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
Eton Pharmaceuticals, Inc. (ETON)
What Is the Price Target for ETON?
SEPT Low Target
$60.00
SEPT Mid Target
$69.00
SEPT High Target
$70.00
Analyst Consensus
$69.00
Is ETON a Buy or Sell Right Now?
Thesis
- •Revenue growing 104.9% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ETON.
Start Free Trial →Is ETON Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$49.96
53
Moat Score
NARROW
4/9
Piotroski Score
11.9
Altman Z-Score
What Is Smart Money Doing with ETON?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| CASAMENTO CHARLES J | director | Buy | 12,500 | $91K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Buy | 27,400 | $98K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Buy | 19,655 | $169K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Buy | 21,000 | $79K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Sale | 6,380 | $410K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Sale | 14,715 | $961K | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Sale | 22,601 | $1.5M | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Sale | 33,956 | $2.3M | Nov 10, 2026 |
| CASAMENTO CHARLES J | director | Sale | 2,903 | $197K | Nov 10, 2026 |
| Erdogan-Trinkaus Ipek | officer | Buy | 3,500 | $54K | Nov 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ETON Growth Story
Revenue YoY
104.9%
3yr Revenue CAGR
55.5%
EPS Growth YoY
N/A
FCF Growth YoY
980.7%
Revenue Trend
ACCELERATING
Dark Pool Trades for ETON
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ETON, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:06:19 | $63.35 | 1,000 | $$63K | SELL |
| 19:05:07 | $63.52 | 1,000 | $$64K | BUY |
| 18:39:51 | $64.52 | 1,000 | $$65K | BUY |
| 17:37:33 | $64.08 | 1,000 | $$64K | BUY |
| 17:30:10 | $63.54 | 1,333 | $$85K | BUY |
5 dark pool trades shown · $$340K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ETON
PREVIEWSEPT Investing provides real-time options flow tracking for ETON, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $70 | Dec 18 | 35 | $$147 | 1 | SWEEP |
| CALL | $35 | May 21 | 189 | $$9210 | 3 | SWEEP |
| CALL | $35 | May 21 | 189 | $$3070 | 1 | SWEEP |
3 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Eton Pharmaceuticals, Inc. (ETON) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ETON — frequently asked questions
What is ETON stock price today?
Eton Pharmaceuticals, Inc. (ETON) is at $63.93, up 4.04% (+$2.48) at the Nov 13, 2026 close.
Why is ETON stock moving today?
Latest ETON news — Nov 12, 2026: Eton Pharmaceuticals, Inc. filed an insider trading report (Form 4) · Nov 12, 2026: Eton Pharmaceuticals Insider Sells $5.3 Million in Shares
What is the ETON price target?
The average analyst price target for ETON is $69.00, ranging from $60 to $70, based on 4 analysts.
What do analysts rate ETON?
Analyst ratings for ETON: 0 Buy, 9 Hold, 0 Sell — consensus Hold.
Did ETON beat earnings?
ETON last reported on Aug 13, 2026: EPS $0.35 vs $0.19 expected — a beat of 84.4%.
What is ETON's P/E ratio?
ETON trades at a P/E of 131.1 vs a Healthcare average of 18.5.
Does ETON pay a dividend?
ETON does not currently pay a dividend.
What are ETON support and resistance levels?
Support: $59.66, $53.98, $47.03. Resistance: $66.37.
What are insiders doing with ETON?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on ETON?
Nov 12, 2026: Eton Pharmaceuticals, Inc. filed an insider trading report (Form 4) · Nov 12, 2026: Eton Pharmaceuticals Insider Sells $5.3 Million in Shares · Nov 10, 2026: B. Riley Securities keeps Buy rating on Eton Pharmaceuticals, lifts target to $81